- Issuer ticker
-
APLS
- Reported as of
-
17 Jan 2025
- Net transaction value
-
-$22,469
- SEC form
-
4
- Accepted by SEC
-
21 Jan 2025, 16:02:18 UTC
Filing notes and source
Key filing fact
Pascal Deschatelets filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 21 Jan 2025.
Key facts
- This page summarizes Pascal Deschatelets's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jan 2025, 16:02.
Change
- Previous filing in this sequence was filed on 14 Jan 2025.
- Current net transaction value: -$22,469.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APLS
transaction
Common Stock
Sale
- Transaction value
- -$22,469
- Shares
- -750
- Change %
- -0.07%
- Price
-
$29.96
- Shares after
- 1,137,445
- Date
- 17 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
APLS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +15,045
- Change %
- +1.3%
- Price
-
$0.000000
- Shares after
- 1,152,490
- Date
- 21 Jan 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes